Myasthenia Gravis

Latest News

myasthenia gravis | Image Credit: © Maggie-sora.chatgpt.com
Unique Psychological Burden of Fear of Progression Seen in MG

August 6th 2025

Fear of progression is common among patients living with chronic diseases, but the degree to which it interferes with patient outcomes, including treatment adherence, deserves further investigation, study authors note.

Myasthenia gravis | Image Credit: lhphotos-stock.adobe.com
Gefurulimab for gMG Meets Key End Points in PREVAIL Trial

July 28th 2025

The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD
The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD

July 23rd 2025

Myasthenia gravis diagnosis | Image Credit: syahrir-stock.adobe.com
Potential Link Found Between Obesity and Myasthenia Gravis Exacerbation

July 15th 2025

Constantine Farmakidis, MD | Image Credit: University of Kansas Medical Center
A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

July 3rd 2025

More News

Image of a nerve cell
February 20th 2023

Live Cell-Based Assays May Find Antibodies in Some Seronegative MG Cases

Jared Kaltwasser
A different type of test may improve diagnosis for some patients with myasthenia gravis (MG).
Image representing a medical report
February 10th 2023

Case Shows Difficulty of Diagnosing Myasthenia Gravis Following COVID-19

Jared Kaltwasser
The patient, an 83-year-old man, experienced onset of myasthenia gravis after a severe SARS-CoV-2 infection.
Patient and doctor holding hands
February 6th 2023

Myasthenia Gravis Likely Leads to Significant Impact on QOL

Jared Kaltwasser
Even patients with the mildest symptoms of myasthenia gravis said they experienced negative quality-of-life (QOL) effects from the disease.
Image of molecular profiling
January 30th 2023

Lower CTLA4 Levels May Indicate Risk of MG in Patients With Thymoma

Jared Kaltwasser
The findings from among patients with myasthenia gravis (MG) could point the way to a potential new drug target, the authors said.
Site Logo
January 28th 2023

Ocular MG Should Be Considered in Patients With Ptosis, Diplopia, Says Study

Jaime Rosenberg
With most previous studies on ocular myasthenia gravis stemming from investigations the neurology field, the present investigators came to their conclusion via neuro-ophthalmic analysis.
picture of an intensive care unit
January 27th 2023

Clarifying the Factors in Myasthenia Gravis That Create Higher HCRU

Allison Inserro
A real-world study of health care resource utilization (HCRU) in patients with myasthenia gravis on second-line therapy identified the factors that led to increased financial burdens.
Image of a hospital room
January 21st 2023

Thymectomy Reduces Hospital Stay From Myasthenia Gravis With Acute Exacerbation

Jaime Rosenberg
The researchers note that this finding adds valuable insight for individualized treatment decisions in scenarios where the role of thymectomy is not fully clear.
Picture of a depressed woman
January 20th 2023

Rates of Depression, Anxiety Higher in MG Than in Other Autoimmune Diseases

Jaime Rosenberg
The systemic review and meta-analysis, believe the researchers, is the first of its kind to characterize the prevalence of depression among these patients.
COVID-19 image
January 10th 2023

COVID-19 May Accelerate Onset of Myasthenia Gravis, Case Study Suggests

Jaime Rosenberg
The researchers hypothesize that SARS-CoV-2 infection may have triggered thymic inflammation, spearheading initial expression of muscle-like epitopes and T-cell dysregulation.
<123456

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo